Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2007 | Volume: 3 | Issue: 2 | Page No.: 204-206
DOI: 10.3923/ijp.2007.204.206
Spontaneous Pneumothorax in a Patient with Osteosarcoma During Treatment with Methotrexate
A. Saadat, N. Jonaidi Jafari, H. Khedmat, H.R. Jalalian, M. Izadi and M.J. Hosseini

Abstract:
Methotrexate is a commonly prescribed antineoplastic and immune modulating compound that has gained wide acceptance in the management of rheumatoid arthritis, psoriasis, sarcoidosis and a number of neoplastic disorders. High dose methotrexate with folinic acid rescue is widely used to treat osteosarcoma, which predominantly afflicts children. Although generally considered safe and easy to use, methotrexate has been associated with a number of adverse reactions. Serious toxicity may affect the lungs, liver and bone marrow. Pulmonary complications of methotrexate may be classified as inflammatory, infectious and possibly neoplastic. We describe a patient with osteosarcoma who presented with leg pain and subsequently developed a spontaneous pneumothorax during treatment with Methotrexate.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

A. Saadat, N. Jonaidi Jafari, H. Khedmat, H.R. Jalalian, M. Izadi and M.J. Hosseini, 2007. Spontaneous Pneumothorax in a Patient with Osteosarcoma During Treatment with Methotrexate. International Journal of Pharmacology, 3: 204-206.

DOI: 10.3923/ijp.2007.204.206

URL: https://scialert.net/abstract/?doi=ijp.2007.204.206

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom